Author:
Agarabi Cyrus,Khan Mansoor A.,Shah Rakhi B.
Reference36 articles.
1. Aldridge S (2009) Moving biotechnology forward with PAT: being proactive instead of passive is the cornerstone of Process analytical technology. Genet Eng Biotechnol News 27:9–15
2. Arnold SA, Gaensakoo R, Harvey LM, McNeil B (2002) Use of at-line and in-situ near-infrared spectroscopy to monitor biomass in an industrial fed-batch Escherichia coli process. Biotechnol Bioeng 80:405–413. doi:10.1002/bit.10383
3. Chen A, Chitta R, Chang D, Amanullah A (2009) Twenty-four well plate miniature bioreactor system as a scale-down model for cell culture process development. Biotechnol Bioeng 102:148–160. doi:10.1002/bit.22031
4. FDA (2004) Guidance for Industry. PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance.
http://www.fda.gov/cder/guidance/6419fnl.pdf
5. FDA notice (2008) Submission of quality information for biotechnology products in the office of biotechnology products: notice of pilot program. Fed Regist 73(128):37972–37974
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献